Pfizer filed an application with the Food and Drug Administration on Thursday seeking emergency use authorization for its coronavirus vaccine that is approved for distribution among children age 5-11.
The FDA said it would look over the application and decide in a matter of weeks, rather than the months these types of applications normally take.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.